| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Altmeyer Anne is a Director at CRBP. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $60K at current prices.
Altmeyer Anne's largest disclosed position is in CRBP as Director, worth about $60K. The recent filings there lean toward selling, a net 4,864 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Sell10b5-1 | 2,412 | $7.91 | $19,087.84 | -24.1% | +37.6% | - | |
| Oct 20, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Sale+OE10b5-1 | 1,060 | $20.50 | $21,730.00 | -14.6% | -53.0% | -75.8% | |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Sell10b5-1 | 1,392 | $7.25 | $10,095.62 | -50.0% | +33.4% | - |